-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Gene therapy is a treatment method
Recently, Zongchao Han's research group from the University of North Carolina used elastin-like polypeptides (ELPs) to encapsulate AAV to form nanoparticles (ELP-AAV), which enhanced the delivery of AAV and gene expression
[Figure 1] (A) Comparison of ELP-AAV entry into cells and ordinary AAV into cells (B) Morphological comparison of ordinary AAV and ELP-AAV (C) Determination of ELP at the junction site (D) of ELP in different serotypeSAAV by MALDI-TOF Transduction efficiency of ELP-AAV on the cell line
【Figure 2】 Transduction efficiency of cell lines under neutralizing antibody conditions for different ELP-AAV and ordinary AAV
【Figure 3】PBS stability (B) of ELP-AAV (A) And stability of serum neutralizing antibodies (C) degradation after entering cells
[Figure 4] Neutralizing antibody titers initiated by ELP-AAV and ordinary AAV(A) injection mice and (B-D) ELP-AAV and ordinary AAV on mouse models of pre-injected neutralizing antibodies are reported gene expression and organ distribution
[Figure 5] ELP-AAV and ordinary AAV (A-C) reported gene expression and organ distribution on mice with pre-stored AAV immunity
WILEY
Thesis Information:
Elastin-Like Polypeptides Facilitate Adeno-Associated Virus Transduction in the Presence of Pre-Existing Neutralizing Antibodies
Kai Wang, Min Zheng, Charles Askew, Xintao Zhang, Chengwen Li, Zongchao Han*
Advanced Therapeutics
DOI:10.
Click "Read the original article" in the lower left corner to view the original text
Advanced
Therapeutics
Journal Introduction
Advanced Therapeutics, Wiley's 2018 sister issue to the Advanced series, is currently covered by Scopus and the Web of Science (ESCI) and will have its first impact factor
AdvancedScienceNews
Wiley's official WeChat platform for scientific research information
Long press the QR code to follow us
Share cutting-edge information| focus on scientific research trends
To publish research news or request information sharing, please contact: ASNChina@Wiley.